BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Oragenics, Inc. (ONI) Drops Its D/B/A ONI BioPharma (ONI) Name


2/2/2009 12:38:15 PM

ALACHUA, FL--(Marketwire - January 30, 2009) - The Florida-based biotechnology firm Oragenics, Inc. (OTCBB: ORNI) announced today that it will not seek shareholder approval to change its corporate name to ONI BioPharma Inc., but will continue to be registered as Oragenics, Inc. In commenting on this decision, Stanley Stein, Oragenics' CEO, stated, "The Oragenics name is well recognized by the investment community and the decision not to seek a name change was taken in order to eliminate any potential confusion in the marketplace regarding the identity of our Company. The Company's common stock will continue trading under the Company's currently registered name of Oragenics, Inc."

About Oragenics

Oragenics, Inc. is a biopharmaceutical company engaged in developing unique proprietary technologies, some of which are being commercialized and sold in the over-the-counter consumer healthcare market. The company also has a number of products in discovery, preclinical and clinical development, with a concentration in the main therapeutic area of infectious diseases, diagnostics, and oral health. The company is located in Progress Corporate Park at 13700 Progress Boulevard in Alachua, Florida, approximately 15 miles from the campus of the University of Florida in Gainesville.


CONTACT:
Linda Loren
Marketing Director
Oragenics, Inc.
727-456-0029
Email Contact


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->